The FDA recently released extensive updates to the consensus standards it recognizes for medical devices. Section 514 of the Food, Drug & Cosmetic Act allows FDA to recognize consensus standards developed by international and national organizations for use in satisfying portions of device premarket review (510(k)) submissions or other requirements. FDA periodically updates the list of such standards that it recognizes and keeps a searchable database available on its website.
The updates included both newly-recognized standards and changes, corrections and withdrawals of existing standards. Categories of devices affected by the changes include anesthesiology, cardiovascular, dental/ENT, general hospital and general plastic surgery, in vitro diagnostics, neurology, OB-GYN/gastroenterology/urology, ophthalmic, orthopedics, physical medicine, radiology, and software/informatics. Changes were also made in the areas of biocompatibility, materials, nanotechnology, and sterility.
The FDA-recognized new standards came in the categories of anesthesia, cardiovascular, general hospital and general plastic surgery, OB-GYN/gastroenterology/urology, ophthalmic, orthopedics, radiology, and software/informatics. New standards were also recognized in the areas of materials and sterility.
For more information, contact the Barnes & Thornburg attorney with whom you work or one of the following attorneys:
Visit us online at www.btlaw.com/food-drug-and-device-law-practices.
© 2014 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is proprietary and the property of Barnes & Thornburg LLP. It may not be reproduced, in any form, without the express written consent of Barnes & Thornburg LLP.
This Barnes & Thornburg LLP publication should not be construed as legal advice or legal opinion on any specific facts or circumstances. The contents are intended for general informational purposes only, and you are urged to consult your own lawyer on any specific legal questions you may have concerning your situation.
Visit us online at www.btlaw.com and follow us on Twitter @BTLawNews.